A s fans patiently wait for the return of Omay Sy's Assane Diop in Lupin Season 4, Netflix has given little to no updates ...

As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035CORAL GABLES, Fla., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst ...

Catalyst Pharmaceuticals agreed to settle its litigation against Lupin Pharmaceuticals over Lupin's application to market a generic version of Catalyst's Lambert-Eaton myasthenic syndrome drug.

A seductive thief takes center stage in this bold anime noir masterpiece that is the perfect next-watch for fans of Cowboy ...

As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The ...

As fans eagerly await the continuation of Assane Diop's captivating journey, the filming for the fourth and final season of Netflix's 'Lupin' is underway and expected to conclude ...

Lupin has partnered with Swiss major Sandoz Group AG to market and commercialise Lupin’s biosimilar ranibizumab across ...

Sandoz will oversee commercialization of the product across the European Union (excluding Germany), Switzerland, Norway, ...

Glucagon is indicated for the treatment of severe hypoglycemia in patients with diabetes mellitus and as a diagnostic aid for ...

Ranibizumab's indications encompass the treatment of patients with Neovascular (Wet) Age-Related Macular Degeneration, and ...

Lupin shares rose 5 per cent after the firm posted a 52 per cent year-on-year increase in net profit in Q1 FY26 ...

Lupin collaborates with Sandoz to commercialize biosimilar ranibizumab in multiple regions. Sandoz to handle ...